Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
14.75
-0.53 (-3.47%)
May 12, 2026, 3:00 PM CST

SHA:603739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
230.01244.16248.73239.6213.87311.83
Trading Asset Securities
267.37224.87199.34292.05212.02170.43
Cash & Short-Term Investments
497.38469.02448.07531.64425.89482.27
Cash Growth
5.38%4.68%-15.72%24.83%-11.69%38.83%
Accounts Receivable
406.39409.27376.58330.26307.72254.31
Other Receivables
45.8441.9728.6825.8332.5136.3
Receivables
452.24451.24405.26356.09347.91298.37
Inventory
230.52226.37188.95205.41173.63157.02
Prepaid Expenses
--1.590.120.130.06
Other Current Assets
57.8531.9825.3130.6821.8434.1
Total Current Assets
1,2381,1791,0691,124969.4971.82
Property, Plant & Equipment
1,4921,5241,5601,5051,260843.51
Long-Term Investments
74.7676.2598.6480.8477.198.59
Goodwill
84.284.284.284.220.2620.26
Other Intangible Assets
129.29126.72131.13139.74135.63131.46
Long-Term Deferred Tax Assets
24.4923.5516.9918.0613.6412.03
Long-Term Deferred Charges
1.471.261.471.411.280.37
Other Long-Term Assets
32.0125.5419.1480.57101.57233.72
Total Assets
3,0763,0402,9813,0342,5792,222
Accounts Payable
215.8194.41224.56231.95147.36112.11
Accrued Expenses
36.7136.27102.0991.7674.2672.89
Short-Term Debt
620.43582.87581.63568.97374.22135.93
Current Portion of Long-Term Debt
-36.1240.0392.88-1
Current Income Taxes Payable
-17.5410.068.4311.678.95
Current Unearned Revenue
22.7214.2511.5110.677.4913.62
Other Current Liabilities
144.89125.6261.5783.5130.127.83
Total Current Liabilities
1,0411,0071,0311,088645.09372.33
Long-Term Debt
50.0659.7913.9662.0614999
Long-Term Unearned Revenue
56.0959.5863.9755.2647.9660.45
Long-Term Deferred Tax Liabilities
2.211.381.463.022.722.88
Other Long-Term Liabilities
1.111.110.150.150.171.52
Total Liabilities
1,1501,1291,1111,209844.93536.18
Common Stock
253.03253.03253.03253.03252.44252.08
Additional Paid-In Capital
702.9702.9702.9712.08705.09693.84
Retained Earnings
858.99841.4796.9759.56704.12674.61
Comprehensive Income & Other
-15.17-14.81-15.1-16.38-16.96-16.03
Total Common Equity
1,8001,7831,7381,7081,6451,605
Minority Interest
126.36128.2132.3117.0989.2281.07
Shareholders' Equity
1,9261,9111,8701,8251,7341,686
Total Liabilities & Equity
3,0763,0402,9813,0342,5792,222
Total Debt
670.49678.78635.62723.92523.22235.93
Net Cash (Debt)
-173.11-209.76-187.55-192.27-97.33246.34
Net Cash Growth
------11.88%
Net Cash Per Share
-0.68-0.84-0.75-0.76-0.381.00
Filing Date Shares Outstanding
255.25225.04253.03253.03252.62252.08
Total Common Shares Outstanding
255.25225.04253.03253.03252.44252.08
Working Capital
197.43171.5337.7535.77324.31599.5
Book Value Per Share
7.057.926.876.756.526.36
Tangible Book Value
1,5861,5721,5221,4841,4891,453
Tangible Book Value Per Share
6.216.986.025.875.905.76
Buildings
--932.34931.6449.85398.83
Machinery
--943.65929.21474.19443.58
Construction In Progress
--203.8175.14704.43315.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.